Inhibitor Therapeutics, Inc. (INTI) Gross margin
Inhibitor Therapeutics, Inc. (INTI) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to INTISource: SEC XBRL filings · For reference only · Not investment advice
More INTI financial trends
INTI RevenueINTI Net incomeINTI Net marginINTI Gross profitINTI Operating incomeINTI Operating marginINTI Operating cash flowINTI Free cash flowINTI Capital expendituresINTI Return on equityINTI Stock buybacksINTI Dividends paidINTI Total assetsINTI Total liabilitiesINTI Shareholders’ equityINTI overview →